496 related articles for article (PubMed ID: 17063460)
1. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling.
Moyers JS; Shiyanova TL; Mehrbod F; Dunbar JD; Noblitt TW; Otto KA; Reifel-Miller A; Kharitonenkov A
J Cell Physiol; 2007 Jan; 210(1):1-6. PubMed ID: 17063460
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma transactivation-mediated potentiation of glucose uptake by Bai-Hu-Tang.
Chen CC; Hsiang CY; Chiang AN; Lo HY; Li CI
J Ethnopharmacol; 2008 Jun; 118(1):46-50. PubMed ID: 18440169
[TBL] [Abstract][Full Text] [Related]
4. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
Kim ED; Kim E; Lee JH; Hyun CK
Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
[TBL] [Abstract][Full Text] [Related]
5. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
[TBL] [Abstract][Full Text] [Related]
6. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
[TBL] [Abstract][Full Text] [Related]
7. Artepillin C, as a PPARγ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
Choi SS; Cha BY; Iida K; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
Biochem Pharmacol; 2011 Apr; 81(7):925-33. PubMed ID: 21219874
[TBL] [Abstract][Full Text] [Related]
8. Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes.
Liao W; Nguyen MT; Yoshizaki T; Favelyukis S; Patsouris D; Imamura T; Verma IM; Olefsky JM
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E219-27. PubMed ID: 17389706
[TBL] [Abstract][Full Text] [Related]
9. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
Sentinelli F; Filippi E; Cavallo MG; Romeo S; Fanelli M; Baroni MG
J Endocrinol; 2006 Feb; 188(2):271-85. PubMed ID: 16461553
[TBL] [Abstract][Full Text] [Related]
10. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling.
Martinez L; Berenguer M; Bruce MC; Le Marchand-Brustel Y; Govers R
Biochem Pharmacol; 2010 May; 79(9):1300-9. PubMed ID: 20026082
[TBL] [Abstract][Full Text] [Related]
12. Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes.
Inukai K; Watanabe M; Nakashima Y; Takata N; Isoyama A; Sawa T; Kurihara S; Awata T; Katayama S
Biochem Biophys Res Commun; 2005 Mar; 328(2):484-90. PubMed ID: 15694373
[TBL] [Abstract][Full Text] [Related]
13. KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects.
Kim KR; Lee JH; Kim SJ; Rhee SD; Jung WH; Yang SD; Kim SS; Ahn JH; Cheon HG
Biochem Pharmacol; 2006 Aug; 72(4):446-54. PubMed ID: 16797489
[TBL] [Abstract][Full Text] [Related]
14. The DLK gene is a transcriptional target of PPARγ.
Couture JP; Blouin R
Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
Fang XK; Gao J; Zhu DN
Life Sci; 2008 Mar; 82(11-12):615-22. PubMed ID: 18262572
[TBL] [Abstract][Full Text] [Related]
16. Reversine stimulates adipocyte differentiation and downregulates Akt and p70(s6k) signaling pathways in 3T3-L1 cells.
Kim YK; Choi HY; Kim NH; Lee W; Seo DW; Kang DW; Lee HY; Han JW; Park SW; Kim SN
Biochem Biophys Res Commun; 2007 Jun; 358(2):553-8. PubMed ID: 17490611
[TBL] [Abstract][Full Text] [Related]
17. Luteolin inhibits adipogenic differentiation by regulating PPARgamma activation.
Park HS; Kim SH; Kim YS; Ryu SY; Hwang JT; Yang HJ; Kim GH; Kwon DY; Kim MS
Biofactors; 2009; 35(4):373-9. PubMed ID: 19353690
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like and non-insulin-like selenium actions in 3T3-L1 adipocytes.
Heart E; Sung CK
J Cell Biochem; 2003 Mar; 88(4):719-31. PubMed ID: 12577306
[TBL] [Abstract][Full Text] [Related]
19. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
Zuo YQ; Liu WP; Niu YF; Tian CF; Xie MJ; Chen XZ; Li L
J Pharm Pharmacol; 2008 Oct; 60(10):1335-40. PubMed ID: 18812026
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.
Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S
Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
